In Case You Missed It: IASLC Launches New Education Center

TERAVOLT: Increased Risk of Morbidity for Patients with Lung Cancer and COVID-19 Drives Research Collaboration

… for Patients with Lung Cancer and COVID-19 Drives Research Collaboration …

The Lung Cancer Research Foundation and Free to Breathe Merge to Fight Lung Cancer

… The Lung Cancer Research Foundation and Free to Breathe Merge to Fight Lung …

Celebrate 5 Decades of the World Conference on Lung Cancer in San Diego’s Historic Gaslamp Quarter

… Dig out your bell bottoms. Search out your leg warmers. Find your flannel. Whether you … honoring the past and embracing the future of lung cancer research and treatment can be purchased when you  register for …

Spotlight on the WCLC 2025 Talent Showcase

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

… with an early-stage non-small-cell lung cancer (NSCLC), research combining prospective and propensity-matched data has … microenvironment and systemic immune responses. 8  Recent research has focused on specific immune cell subsets, such as … with SABR. Substantial clinical and translational research is essential to establish the true effectiveness and …

IASLC Launches Global Member Survey on Diversity, Equity, and Inclusion

Challenges of Systemic Therapy for Patients with EGFR-mutated Lung Cancer After Progression on Targeted Therapy

… of ADCs with TKIs. 18  Learn more about the latest in ADC research here. Physicians and patients alike question which … failure of EGFR-TKI therapy. Translational Lung Cancer Research. 2021;10(9):3782-92. 7.  Itchins M, Ainsworth H, … COMPARING OUTCOMES OF VARIOUS TREATMENT REGIMENS IN THE SEARCH FOR THE BEST-PERFORMING APPROACH. … Challenges of …

Opening Plenary to Highlight Significant Achievements in Thoracic Oncology

A New Treatment Option for Early-Stage ALK+ NSCLC: Adjuvant Alectinib

… in Victoria, Australia. His clinical and translational research has identified new treatments, changed the standards … in Victoria, Australia. His clinical and translational research has identified new treatments, changed the standards …

Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question

Should Biomarkers Be Used in the Clinical Management of ES-SCLC?

… not there yet. We can’t force it.” He said having recent research that has demonstrated the heterogeneity of SCLC is a huge first step. As is other recent research showing that liquid biopsy can be used to identify …